We’ve uncovered a list of what we consider to be five recession-proof dividend stocks yielding over 6%, much higher than the ...

Barron’s has long favored dividend-paying stocks for those seeking income. But bonds now deserve a hard look because they are ...

Pfizer has earned a consensus rating of “Moderate Buy” from fifteen analysts, with only one calling it a “sell.” The average ...

The dividend record date is when a company finalises eligible shareholders for dividend, e.g., if a company sets June 27, ...

Pfizer (NYSE:PFE) recently announced positive topline results from its Phase 3 BASIS study for HYMPAVZI™ and declared a third ...

Pfizer will pay a $0.43 quarterly dividend on September 2, 2025, maintaining its 347-quarter streak of shareholder payouts.

Pfizer's revenue slump is temporary. New launches and Seagen integration drive 2025 growth. Read here for an investment ...

Importantly, Pfizer Inc. (NYSE:PFE) does carry debt. But is this debt a concern to shareholders? We've found 21 US stocks ...

With continued uncertainty over Washington's policy priorities plus a recent flare-up of geopolitical tensions in the Middle East, it seems like Wall Street may continue to focus on ...

Pfizer Inc. (NYSE:PFE) is one of the Best Dividend Leaders to Buy Now. The company’s strategy focuses on steadily increasing ...

Manulife Philippines has partnered with Pfizer to promote disease awareness and patient education, as part of its Better Days ...

Pfizer’s 7%+ yield is tempting, but rising political, regulatory, and business risks threaten its stability and growth ...